Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis.

[1]  C. Hassan,et al.  Endoscopic treatment of variceal upper gastrointestinal bleeding: European Society of Gastrointestinal Endoscopy (ESGE) Cascade Guideline , 2020, Endoscopy International Open.

[2]  T. Pham,et al.  Usefulness of Mac-2 binding protein glycosylation isomer in non-invasive probing liver disease in the Vietnamese population , 2020, World Journal of Hepatology.

[3]  Chia-Yang Hsu,et al.  Outcomes after hepatic encephalopathy in population‐based cohorts of patients with cirrhosis , 2020, Alimentary pharmacology & therapeutics.

[4]  E. Tapper,et al.  Comprehensive Health‐State Utilities in Contemporary Patients With Cirrhosis , 2020, Hepatology communications.

[5]  J. Aitken,et al.  Global Trends in Incidence Rates of Primary Adult Liver Cancers: A Systematic Review and Meta-Analysis , 2020, Frontiers in Oncology.

[6]  A. Lok,et al.  Chronic Hepatitis B Prevalence Among Foreign‐Born and U.S.‐Born Adults in the United States, 1999‐2016 , 2020, Hepatology.

[7]  R. Bataller,et al.  Alcohol-Related Liver Disease Is Rarely Detected at Early Stages Compared With Liver Diseases of Other Etiologies Worldwide. , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[8]  B. Turner,et al.  Evaluation of a Multifaceted Intervention to Reduce Health Disparities in Hepatitis C Screening: A Pre‐Post Analysis , 2019, Hepatology.

[9]  J. Kramer,et al.  Reply to: "Prevalence and short-term mortality in a national US cohort with acute-on-chronic liver failure". , 2019, Journal of hepatology.

[10]  N. Krieger,et al.  The burden of non-alcoholic steatohepatitis (NASH) among patients from Europe: A real-world patient-reported outcomes study , 2019, JHEP reports.

[11]  F. Tacke,et al.  Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis , 2019, Hepatology.

[12]  A. Singal,et al.  Prevalence of Alcoholic Fatty Liver Disease Among Adults in the United States, 2001-2016 , 2019, JAMA.

[13]  V. Wong,et al.  Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis. , 2019, The lancet. Gastroenterology & hepatology.

[14]  H. El‐Serag,et al.  Awareness of chronic viral hepatitis in the United States: An update from the National Health and Nutrition Examination Survey , 2019, Journal of viral hepatitis.

[15]  H. Hagan,et al.  On the way to Hepatitis C elimination in the Republic of Georgia—Barriers and facilitators for people who inject drugs for engaging in the treatment program: A formative qualitative study , 2019, PloS one.

[16]  A. Lok,et al.  Frailty, Psychoactive Medications, and Cognitive Dysfunction Are Associated With Poor Patient‐Reported Outcomes in Cirrhosis , 2019, Hepatology.

[17]  N. Sheron,et al.  No safe level of alcohol consumption - Implications for global health. , 2019, Journal of hepatology.

[18]  H. Van Vlierberghe,et al.  Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide. , 2019, Gastroenterology.

[19]  C. Booth,et al.  Incidence of cirrhosis in young birth cohorts in Canada from 1997 to 2016: a retrospective population-based study. , 2019, The lancet. Gastroenterology & hepatology.

[20]  Z. Younossi.  Non-alcoholic fatty liver disease - A global public health perspective. , 2019, Journal of hepatology.

[21]  R. Peeling,et al.  Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission. , 2019, The lancet. Gastroenterology & hepatology.

[22]  J. Marrero,et al.  Racial and Ethnic Differences in Presentation and Outcomes of Hepatocellular Carcinoma , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[23]  Jennifer L Lund,et al.  Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018. , 2019, Gastroenterology.

[24]  P. Kamath,et al.  Burden of liver diseases in the world. , 2019, Journal of hepatology.

[25]  V. Beral,et al.  Alcohol drinking patterns and liver cirrhosis risk: analysis of the prospective UK Million Women Study , 2018, The Lancet. Public health.

[26]  Haniye Sadat Sajadi,et al.  Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2018, Lancet.

[27]  Jonathan Mermin,et al.  Estimating Prevalence of Hepatitis C Virus Infection in the United States, 2013‐2016 , 2018, Hepatology.

[28]  K. Kerr,et al.  Development of models estimating the risk of hepatocellular carcinoma after antiviral treatment for hepatitis C. , 2018, Journal of hepatology.

[29]  G. Su,et al.  A risk score to predict the development of hepatic encephalopathy in a population‐based cohort of patients with cirrhosis , 2018, Hepatology.

[30]  Dan J Stein,et al.  Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2018, Lancet.

[31]  R. Fontana,et al.  The high burden of alcoholic cirrhosis in privately insured persons in the United States , 2018, Hepatology.

[32]  J. Lazarus,et al.  Burden of liver disease in Europe: Epidemiology and analysis of risk factors to identify prevention policies. , 2018, Journal of hepatology.

[33]  S. Ng,et al.  The changing epidemiology of liver diseases in the Asia–Pacific region , 2018, Nature Reviews Gastroenterology & Hepatology.

[34]  P. Easterbrook,et al.  Access to Treatment for Hepatitis B Virus Infection — Worldwide, 2016 , 2018, MMWR. Morbidity and mortality weekly report.

[35]  E. Tapper,et al.  Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study , 2018, British Medical Journal.

[36]  G. McCaughan,et al.  Frailty in advanced liver disease , 2018, Liver international : official journal of the International Association for the Study of the Liver.

[37]  M. Volk,et al.  Patient‐reported outcomes in cirrhosis: A scoping review of the literature , 2018, Hepatology.

[38]  T. Therneau,et al.  Nonalcoholic fatty liver disease incidence and impact on metabolic burden and death: A 20 year‐community study , 2018, Hepatology.

[39]  R. Jhaveri,et al.  Individual State Hepatitis C Data Supports Expanding Screening Beyond Baby Boomers to All Adults. , 2018, Gastroenterology.

[40]  N. LaRusso,et al.  Milder disease stage in patients with primary biliary cholangitis over a 44‐year period: A changing natural history , 2018, Hepatology.

[41]  A. Giuliano,et al.  Hepatitis C Virus Screening Trends: Serial Cross-Sectional Analysis of the National Health Interview Survey Population, 2013–2015 , 2018, Cancer Epidemiology, Biomarkers & Prevention.

[42]  M. Shiffman,et al.  Race/ethnicity and insurance status disparities in access to direct acting antivirals for hepatitis C virus treatment , 2018, The American Journal of Gastroenterology.

[43]  L. Tavoschi,et al.  Hepatitis B/C in the countries of the EU/EEA: a systematic review of the prevalence among at-risk groups , 2018, BMC Infectious Diseases.

[44]  Peter J. Richardson,et al.  Positive Predictive Value of International Classification of Diseases, 10th Revision, Codes for Cirrhosis and Its Related Complications , 2018, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[45]  P. Angeli,et al.  Infections complicating cirrhosis , 2018, Liver international : official journal of the International Association for the Study of the Liver.

[46]  J. Lazarus,et al.  Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe. , 2018, The lancet. Gastroenterology & hepatology.

[47]  K. Lindor,et al.  Increasing Prevalence of Primary Biliary Cholangitis and Reduced Mortality With Treatment , 2017, Clinical Gastroenterology and Hepatology.

[48]  I. Waked,et al.  Planning and prioritizing direct-acting antivirals treatment for HCV patients in countries with limited resources: Lessons from the Egyptian experience. , 2017, Journal of hepatology.

[49]  Rohit Loomba,et al.  Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease , 2017, Hepatology.

[50]  S. Olafsson,et al.  Modelling the elimination of hepatitis C as a public health threat in Iceland: A goal attainable by 2020. , 2017, Journal of hepatology.

[51]  Namkug Kim,et al.  Increasing burden of liver cancer despite extensive use of antiviral agents in a hepatitis B virus‐endemic population , 2017, Hepatology.

[52]  Alan D. Lopez,et al.  The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level , 2017, JAMA oncology.

[53]  G. D’Amico,et al.  Clinical states of cirrhosis and competing risks. , 2017, Journal of hepatology.

[54]  S. Asch,et al.  Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents. , 2017, Gastroenterology.

[55]  J. Browning,et al.  Racial and Ethnic Disparities in Nonalcoholic Fatty Liver Disease Prevalence, Severity, and Outcomes in the United States: A Systematic Review and Meta‐analysis , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[56]  Mohammad Hossein Khosravi,et al.  Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2017, Lancet.

[57]  H. El‐Serag,et al.  Role of Age and Race in the Risk of Hepatocellular Carcinoma in Veterans With Hepatitis B Virus Infection , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[58]  S. Saini,et al.  Suboptimal Implementation of Evidence‐based Therapy for Acute Variceal Hemorrhage: A Systematic Review of Observational Studies , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[59]  Jennifer C Lai,et al.  Development of a novel frailty index to predict mortality in patients with end‐stage liver disease , 2017, Hepatology.

[60]  N. Chalasani,et al.  Most Individuals With Advanced Cirrhosis Have Sleep Disturbances, Which Are Associated With Poor Quality of Life , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[61]  H. El‐Serag,et al.  Incidence and Determinants of Hepatocellular Carcinoma in Autoimmune Hepatitis: A Systematic Review and Meta‐analysis , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[62]  T. Vos,et al.  Global, regional, and national incidence and prevalence, and years lived with disability for 328 diseases and injuries in 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2017 .

[63]  J. West,et al.  Liver cirrhosis in England—an observational study: are we measuring its burden occurrence correctly? , 2017, BMJ Open.

[64]  A. L. Mindikoglu,et al.  New Developments in Hepatorenal Syndrome , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[65]  M. Stepanova,et al.  Direct and Indirect Economic Burden of Chronic Liver Disease in the United States , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[66]  G. Ioannou,et al.  Transformation of hepatitis C antiviral treatment in a national healthcare system following the introduction of direct antiviral agents , 2017, Alimentary pharmacology & therapeutics.

[67]  E. Gorospe,et al.  Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation. , 2017, Gastroenterology.

[68]  William Carey,et al.  Prevalence of Nonalcoholic Steatohepatitis-Associated Cirrhosis in the United States: An Analysis of National Health and Nutrition Examination Survey Data , 2017, The American Journal of Gastroenterology.

[69]  P. Kamath,et al.  Hepatic Encephalopathy Is Associated With Mortality in Patients With Cirrhosis Independent of Other Extrahepatic Organ Failures , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[70]  Gamal Esmat,et al.  Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. , 2017, The lancet. Gastroenterology & hepatology.

[71]  H. El‐Serag,et al.  Incidence of Hepatocellular Carcinoma in All 50 United States, From 2000 Through 2012. , 2017, Gastroenterology.

[72]  J. Albrecht,et al.  Markedly Increased Rate of Primary Liver Malignancies at Autopsy in Male US Veterans , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[73]  Z. Zou,et al.  Disease spectrum of alcoholic liver disease in Beijing 302 Hospital from 2002 to 2013 , 2017, Medicine.

[74]  M. Volk,et al.  Strategies to Reduce 30-Day Readmissions in Patients with Cirrhosis , 2017, Current Gastroenterology Reports.

[75]  R. Moreau,et al.  Acute-on-chronic liver failure: an update , 2017, Gut.

[76]  N. Alexander,et al.  Performance-Based Measures Associate With Frailty in Patients With End-Stage Liver Disease , 2016, Transplantation.

[77]  P. Kamath,et al.  Time trends in the health care burden and mortality of acute on chronic liver failure in the United States , 2016, Hepatology.

[78]  Robert Blissett,et al.  The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe , 2016, Hepatology.

[79]  Reza Assadi,et al.  The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013 , 2016, The Lancet.

[80]  E. Tapper,et al.  Rates of and Reasons for Hospital Readmissions in Patients With Cirrhosis: A Multistate Population-based Cohort Study. , 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[81]  E. Guallar,et al.  Metabolically Healthy Obesity and the Development of Nonalcoholic Fatty Liver Disease , 2016, The American Journal of Gastroenterology.

[82]  R. Hultcrantz,et al.  Overweight in late adolescence predicts development of severe liver disease later in life: A 39years follow-up study. , 2016, Journal of hepatology.

[83]  L. Henry,et al.  Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes , 2016, Hepatology.

[84]  Vikram Patel,et al.  Global burden of diseases, injuries, and risk factors for young people's health during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2016, The Lancet.

[85]  P. Haber,et al.  Alcoholic Liver Disease in Asia, Europe, and North America. , 2016, Gastroenterology.

[86]  L. Henry,et al.  Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the World. , 2016, Clinics in liver disease.

[87]  E. Tapper,et al.  Preventing and Treating Acute Kidney Injury Among Hospitalized Patients with Cirrhosis and Ascites: A Narrative Review. , 2016, The American journal of medicine.

[88]  H. Vilstrup,et al.  Decreasing Mortality Among Danish Alcoholic Cirrhosis Patients: A Nationwide Cohort Study , 2016, The American Journal of Gastroenterology.

[89]  N. Sheron.  Alcohol and liver disease in Europe--Simple measures have the potential to prevent tens of thousands of premature deaths. , 2016, Journal of hepatology.

[90]  K. Covinsky,et al.  Functional decline in patients with cirrhosis awaiting liver transplantation: Results from the functional assessment in liver transplantation (FrAILT) study , 2016, Hepatology.

[91]  H. El‐Serag,et al.  Trends in the Burden of Nonalcoholic Fatty Liver Disease in a United States Cohort of Veterans. , 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[92]  S. Holmberg,et al.  Prevalence of chronic hepatitis B virus (HBV) infection in U.S. households: National Health and Nutrition Examination Survey (NHANES), 1988‐2012 , 2016, Hepatology.

[93]  L. Nguyen,et al.  Rates of Treatment Eligibility in Follow-Up of Patients with Chronic Hepatitis B (CHB) Across Various Clinical Settings Who Were Initially Ineligible at Presentation , 2016, Digestive Diseases and Sciences.

[94]  B. McMahon,et al.  Antiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and meta‐analysis , 2016, Hepatology.

[95]  Jason A. Dominitz,et al.  Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013. , 2015, Gastroenterology.

[96]  D. Lawlor,et al.  The Prevalence of Non-Alcoholic Fatty Liver Disease in Children and Adolescents: A Systematic Review and Meta-Analysis , 2015, PloS one.

[97]  Gérard Krause,et al.  Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013 , 2015, The Lancet.

[98]  E. Tapper,et al.  Psychoactive Medications Increase the Risk of Falls and Fall-related Injuries in Hospitalized Patients With Cirrhosis. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[99]  Michael L. Volk,et al.  The Epidemiology of Cirrhosis in the United States: A Population-based Study , 2015, Journal of clinical gastroenterology.

[100]  A. Walker,et al.  Causes of Death in People with Liver Cirrhosis in England Compared with the General Population: A Population-Based Cohort Study , 2015, The American Journal of Gastroenterology.

[101]  A. de Gottardi,et al.  Clinical Course of acute‐on‐chronic liver failure syndrome and effects on prognosis , 2015, Hepatology.

[102]  T. Sørensen,et al.  Body mass index in school-aged children and the risk of routinely diagnosed non-alcoholic fatty liver disease in adulthood: a prospective study based on the Copenhagen School Health Records Register , 2015, BMJ Open.

[103]  R. Moreau,et al.  Acute-on-chronic liver failure: A new syndrome that will re-classify cirrhosis. , 2015, Journal of hepatology.

[104]  A. Moorman,et al.  Predictors of poor mental and physical health status among patients with chronic hepatitis C infection: The Chronic Hepatitis Cohort Study (CHeCS) , 2015, Hepatology.

[105]  W. Kim,et al.  Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites , 2015, Gut.

[106]  J. Talwalkar,et al.  Improving quality of health care for patients with cirrhosis. , 2014, Gastroenterology.

[107]  J. Eriksson,et al.  Higher fructose intake is inversely associated with risk of nonalcoholic fatty liver disease in older Finnish adults. , 2014, The American journal of clinical nutrition.

[108]  Mohsen Naghavi,et al.  Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis , 2014, BMC Medicine.

[109]  P. Byass.  The global burden of liver disease: a challenge for methods and for public health , 2014, BMC Medicine.

[110]  K. Covinsky,et al.  Frailty Predicts Waitlist Mortality in Liver Transplant Candidates , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[111]  J. Lazarus,et al.  Hepatitis C Virus Infection Epidemiology among People Who Inject Drugs in Europe: A Systematic Review of Data for Scaling Up Treatment and Prevention , 2014, PloS one.

[112]  C. Umscheid,et al.  The Treatment Cascade for Chronic Hepatitis C Virus Infection in the United States: A Systematic Review and Meta-Analysis , 2014, PloS one.

[113]  Z. Halpern,et al.  Non‐high‐density lipoprotein cholesterol independently predicts new onset of non‐alcoholic fatty liver disease , 2014, Liver international : official journal of the International Association for the Study of the Liver.

[114]  K. Reddy,et al.  Survival in infection‐related acute‐on‐chronic liver failure is defined by extrahepatic organ failures , 2014, Hepatology.

[115]  G. D’Amico,et al.  Competing risks and prognostic stages of cirrhosis: a 25‐year inception cohort study of 494 patients , 2014, Alimentary pharmacology & therapeutics.

[116]  J. Ward,et al.  Chronic Hepatitis C Virus Infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010 , 2014, Annals of Internal Medicine.

[117]  H. Vilstrup,et al.  Autoimmune hepatitis in Denmark: incidence, prevalence, prognosis, and causes of death. A nationwide registry-based cohort study. , 2014, Journal of hepatology.

[118]  S. J. Henley,et al.  Changing Hepatocellular Carcinoma Incidence and Liver Cancer Mortality Rates in the United States , 2014, The American Journal of Gastroenterology.

[119]  S. Hadler,et al.  The impact of hepatitis B vaccine in China and in the China GAVI Project. , 2013, Vaccine.

[120]  V. Novack,et al.  Autoimmune hepatitis in southern Israel: A 15‐year multicenter study , 2013, Journal of digestive diseases.

[121]  R. Arnaout,et al.  The overuse of serum ceruloplasmin measurement. , 2013, The American journal of medicine.

[122]  A. Frigo,et al.  Evaluation of the Acute Kidney Injury Network criteria in hospitalized patients with cirrhosis and ascites. , 2013, Journal of hepatology.

[123]  S. Thorgeirsson,et al.  Dramatic reduction of liver cancer incidence in young adults: 28 year follow-up of etiological interventions in an endemic area of China. , 2013, Carcinogenesis.

[124]  Terry M. Therneau,et al.  Underestimation of liver-related mortality in the United States. , 2013, Gastroenterology.

[125]  Jürgen Rehm,et al.  Global burden of alcoholic liver diseases. , 2013, Journal of hepatology.

[126]  R. Moreau,et al.  Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. , 2013, Gastroenterology.

[127]  Magnus Rattray,et al.  A genetic study of Wilson's disease in the United Kingdom. , 2013, Brain : a journal of neurology.

[128]  H. El‐Serag,et al.  Epidemiology of viral hepatitis and hepatocellular carcinoma. , 2012, Gastroenterology.

[129]  C. Ponsioen,et al.  Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review. , 2012, Journal of hepatology.

[130]  Yongjian Zhou,et al.  Natural course of nonalcoholic fatty liver disease in southern China: A prospective cohort study , 2012, Journal of digestive diseases.

[131]  K. Flegal,et al.  Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010. , 2012, JAMA.

[132]  J. West,et al.  All‐cause mortality in people with cirrhosis compared with the general population: a population‐based cohort study , 2012, Liver international : official journal of the International Association for the Study of the Liver.

[133]  K. Langa,et al.  Burden of cirrhosis on older Americans and their families: Analysis of the health and retirement study , 2012, Hepatology.

[134]  R. Bataller,et al.  Alcoholic liver disease: pathogenesis and new therapeutic targets. , 2011, Gastroenterology.

[135]  A. Sanyal,et al.  The Multi-Dimensional Burden of Cirrhosis and Hepatic Encephalopathy on Patients and Caregivers , 2011, The American Journal of Gastroenterology.

[136]  M. Pavesi,et al.  Prognostic importance of the cause of renal failure in patients with cirrhosis. , 2011, Gastroenterology.

[137]  J. West,et al.  The rate of decompensation and clinical progression of disease in people with cirrhosis: a cohort study , 2010, Alimentary pharmacology & therapeutics.

[138]  C. Stedman,et al.  Population‐based epidemiology study of autoimmune hepatitis: A disease of older women? , 2010, Journal of gastroenterology and hepatology.

[139]  E. Björnsson,et al.  Incidence and prevalence of primary sclerosing cholangitis in a defined adult population in sweden , 2010, Hepatology.

[140]  M. Miquel,et al.  Incidence and prognosis of different types of functional renal failure in cirrhotic patients with ascites. , 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[141]  H. Sørensen,et al.  Clinical course of alcoholic liver cirrhosis: A Danish population‐based cohort study , 2010, Hepatology.

[142]  A. Rigotti,et al.  Non‐alcoholic fatty liver disease and its association with obesity, insulin resistance and increased serum levels of C‐reactive protein in Hispanics , 2009, Liver international : official journal of the International Association for the Study of the Liver.

[143]  C. Parikh,et al.  Acute kidney injury in cirrhosis , 2008, Hepatology.

[144]  M. Omary,et al.  Epidemiology of alcohol-related liver and pancreatic disease in the United States. , 2008, Archives of internal medicine.

[145]  A. Bergquist,et al.  Epidemiology and the initial presentation of autoimmune hepatitis in Sweden: A nationwide study , 2008, Scandinavian journal of gastroenterology.

[146]  G. Bedogni,et al.  Incidence and natural course of fatty liver in the general population: The Dionysos study , 2007, Hepatology.

[147]  J. Goodwin,et al.  Epidemiology of hepatocellular carcinoma in Hispanics in the United States. , 2007, Archives of internal medicine.

[148]  D. Parkin,et al.  The evolution of the population-based cancer registry , 2006, Nature Reviews Cancer.

[149]  D. Reboussin,et al.  Liver diseases in the hemochromatosis and iron overload screening study. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[150]  E. Thomson,et al.  Hemochromatosis and iron-overload screening in a racially diverse population. , 2005, The New England journal of medicine.

[151]  Jonathan C. Cohen,et al.  Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity , 2004, Hepatology.

[152]  M. Gravenor,et al.  Incidence, clinical patterns, and outcomes of primary sclerosing cholangitis in South Wales, United Kingdom. , 2004, Gastroenterology.

[153]  T. Therneau,et al.  Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. , 2003, Gastroenterology.

[154]  J. Feld,et al.  Epidemiology of autoimmune liver disease , 2003, Journal of gastroenterology and hepatology.

[155]  M. Worwood,et al.  Hereditary haemochromatosis: only 1% of adult HFE C282Y homozygotes in South Wales have a clinical diagnosis of iron overload , 2002, Human Genetics.

[156]  B. McMahon,et al.  Prevalence of autoimmune liver disease in Alaska natives , 2002, American Journal of Gastroenterology.

[157]  J. Koziol,et al.  Penetrance of 845G→A (C282Y) HFE hereditary haemochromatosis mutation in the USA , 2002, The Lancet.

[158]  T. Therneau,et al.  Epidemiology and natural history of primary biliary cirrhosis in a US community. , 2000, Gastroenterology.

[159]  H. El‐Serag,et al.  Rising Incidence of Hepatocellular Carcinoma in the United States , 1999, Infection Control & Hospital Epidemiology.

[160]  W. Jiménez,et al.  Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. , 1993, Gastroenterology.

[161]  C. Murphy,et al.  Hepatocellular Carcinoma Incidence Is Decreasing Among Younger Adults in the United States. , 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[162]  J. Talwalkar,et al.  Trends in Chronic Liver Disease-Related Hospitalizations: A Population-Based Study , 2019, The American Journal of Gastroenterology.

[163]  R. Mikolajczyk,et al.  Time trends of chronic HBV infection over prior decades - A global analysis. , 2017, Journal of hepatology.

[164]  Z. Zou,et al.  Disease spectrum of alcoholic liver disease in beijing 302 hospital from 2002 to 2013: a large tertiary referral hospital experience from 7,422 patients , 2017 .

[165]  V. Wong,et al.  Incidence of non-alcoholic fatty liver disease in Hong Kong: a population study with paired proton-magnetic resonance spectroscopy. , 2015, Journal of hepatology.

[166]  G. D’Amico,et al.  Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. , 2006, Journal of hepatology.

[167]  A. Chlumská,et al.  [Alcoholic hepatitis]. , 1987, Casopis lekaru ceskych.